Chiesi’s Elfabrio receives NICE recommendation by John Pinching | Sep 4, 2023 | News | 0 The therapy has been developed for the treatment of Fabry disease among adult patients Read More
Institute of Cancer Research embraces olaparib recommendation by John Pinching | Apr 6, 2023 | News | 0 Vital AstraZeneca therapy may transform lives of people with certain breast and prostate cancers Read More
Novartis’ Beovu recommended by NICE by John Pinching | Jul 28, 2022 | News | 0 Patients set to benefit from new treatment for sight-threatening eye condition Read More
NICE recommends Opdivo as post-surgery treatment by John Pinching | Jul 8, 2022 | News | 0 The therapy will be used for specific muscle invasive urothelial cancer patients Read More
Hundreds of urothelial cancer patients to receive new treatment by John Pinching | Apr 7, 2022 | News | 0 NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer Read More